PRESS RELEASE: Callisto Medical Announces How to Look Good and Feel Great Seminar in Denver on August 1

Callisto Medical Announces How to Look Good and Feel Great Seminar in Denver on August 1

Learn How Childhood Habits Can Lead to a Healthier Life

DENVER, July 26 -- Callisto Medical offers an entertaining and informative look at developing healthier habits to fit a busy lifestyle at its upcoming “How to Look Good and Feel Great” seminar. The featured speaker at the event is Dr. Kelly Sennholz.

Given America’s current health insurance system, it is more vital than ever for patients to learn how to create their own lifelong health. Dr. Sennholz examines whether some of today’s most popular treatments are truly beneficial. In addition, she’ll discuss approaches that individuals can do on their own that actually help prevent Obesity, Metabolic Syndrome, Diabetes, Heart Disease, Cancer, Dementia and many others.

Did you know Osteoporosis is a disease actually rooted in childhood? The talk will also focus on strategies to create lifelong health for children. Maintaining health early in life is more important than most people realize. Learn how to keep yourself, your children and all your loved ones healthy for life!

Location: Ptarmigan Building, 3773 Cherry Creek North Drive, Denver

Date: August 1, 2007

Time: Registration: 6:30 p.m.; Event: 7:00 p.m. - 8:30 p.m.

Cost: $10.00 per person

For more information or to purchase tickets, visit www.denverhealthyforlife.com or call 303-744-3100. Space is limited.

Media interviews can be scheduled by contacting Dr. Sennholz directly at 303-887-1072 or [email protected]

About Callisto Medical:

Callisto Medical was founded by Kelly Z. Sennholz, M.D., who is board-certified in Emergency Medicine and Internal Medicine. Dr. Sennholz is a frequent speaker on how to begin a lifelong practice of healthy habits and how to take control of your own health. She motivates and inspires people to achieve peak performance in all aspects of life. For more information about the event, visit www.denverhealthyforlife.com.

Suggested Articles

Bristol Myers Squibb may have bounced Jounce from its roster of inherited partners, but it’s hanging onto Anokion, a Swiss autoimmune-focused biotech.

The priority review action date sets Bristol Myers up to win approval for the bluebird-partnered anti-BCMA CAR-T therapy in late March.

The unidentified biotechs are drawn from the portfolio of a €150 million life science-focused fund that Index Ventures set up.